Medullary breast cancer is a rare form of invasive breast cancer that develops in the milk ducts before extending into nearby breast tissue. Although it may appear aggressive under a microscope, this uncommon cancer subtype often grows more slowly and is less likely to spread than many other forms of breast cancer.
Experts estimate that medullary breast cancer accounts for only a small percentage of all breast cancer cases, making it one of the less common diagnoses among patients with invasive breast disease.
What Is Medullary Breast Cancer?
Medullary breast cancer is considered a subtype of invasive ductal carcinoma, the most frequently diagnosed form of breast cancer. The condition gets its name from the tumor’s soft, fleshy appearance, which resembles the medulla, a structure found within the brain.
Unlike many invasive cancers, medullary tumors are often surrounded by immune system cells, including lymphocytes. Researchers believe these immune cells may help limit the tumor’s ability to spread, contributing to its generally favorable prognosis.
The disease most commonly affects women in middle age, although it can occur at any age.
Symptoms
In its early stages, medullary breast cancer may not cause noticeable symptoms. As the tumor grows, however, individuals may detect changes in the breast, including:
- A new breast lump or mass
- Breast tenderness or discomfort
- Swelling in part of the breast
- Skin redness or irritation
- Dimpling or thickening of the breast skin
- Changes to the nipple, including pain or discharge
- Unusual nipple secretions
Because these symptoms can also occur with other breast conditions, medical evaluation is important for an accurate diagnosis.
Possible Causes and Risk Factors
The exact cause of medullary breast cancer remains unclear. However, genetic factors appear to play an important role.
Research has linked the condition to mutations in the BRCA1 gene, a hereditary gene alteration associated with an increased risk of breast and ovarian cancers. Individuals carrying this mutation may face a higher likelihood of developing medullary breast cancer compared with the general population.
Unlike some other breast cancer types, hormone-related factors appear to play a less significant role in the development of medullary tumors.
Diagnosis
Diagnosing medullary breast cancer can be challenging because its cells may resemble those found in other forms of invasive ductal carcinoma.
Doctors typically use several tools to confirm a diagnosis, including:
- Clinical breast examinations
- Mammograms
- Breast ultrasound scans
- Magnetic resonance imaging (MRI)
- Tissue biopsy and laboratory analysis
A biopsy remains the most reliable method for identifying the specific characteristics of the tumor and determining the most appropriate treatment plan.
Treatment Options
Treatment depends on factors such as tumor size, cancer stage, lymph node involvement, and the biological characteristics of the cancer cells.
Surgery
Surgery is often the primary treatment and may involve:
- Lumpectomy: Removal of the tumor while preserving most of the breast tissue.
- Mastectomy: Removal of the entire breast when necessary.
Radiation Therapy
Radiation treatment may be recommended after surgery to eliminate any remaining cancer cells and reduce the risk of recurrence.
Chemotherapy
Chemotherapy uses medications to destroy cancer cells throughout the body and may be advised in certain cases, particularly if there is concern about cancer spread.
Targeted Therapy
Targeted treatments focus on specific proteins or genetic features that help cancer cells grow and survive.
Hormone Therapy
Hormone therapy may be used for cancers that rely on hormones for growth. However, many medullary breast cancers lack hormone receptors, making hormone-based treatments less effective in those cases.
Survival and Prognosis
Medullary breast cancer is generally associated with favorable outcomes when diagnosed and treated early.
Because the cancer tends to grow slowly and has a lower likelihood of spreading to lymph nodes or distant organs, many patients experience excellent long-term survival.
Studies have reported high survival rates, with the majority of patients remaining alive five and ten years after diagnosis. Outcomes are particularly positive when the cancer is detected before it has spread beyond the breast.
Outlook
The outlook for people diagnosed with medullary breast cancer is often better than that of many other invasive breast cancer subtypes. Early detection, accurate diagnosis, and timely treatment significantly improve the chances of successful outcomes.
Regular breast screening, awareness of breast changes, and prompt medical attention for unusual symptoms remain important tools in identifying breast cancer at its earliest and most treatable stages.
Conclusion
Medullary breast cancer is a rare subtype of invasive breast cancer that typically grows more slowly and spreads less frequently than many other forms of the disease. While its appearance may suggest an aggressive tumor, patients often respond well to treatment and enjoy positive long-term outcomes.
Awareness, routine screening, and early medical evaluation continue to play a vital role in improving survival and overall quality of life for those affected by this uncommon breast cancer.
